Indian venture capitalists hold billions, but the traditional funding model faces disruption. Founders now build and scale businesses with ...

Natco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young ...

Branded generics also add significant value to the healthcare ecosystem. They develop and circulate patient education materials. In-patient...

Amazon has invested more than $900 million and employed more than 12,000 people dedicated to protecting customers and brands.

BI said the injunctions restrain the domestic pharma companies from infringing the patent of Linagliptin by advertising, launching, making,...

A steady increase in drug approvals and portfolio rationalisation by MNCs resulted in India’s volume share rising by 5% over the last few m...

The Bengaluru-based firm had inked a pact to acquire 51 per cent stake in Australia's Generic Partners Holdings Co for AUD 15 million and a...

Shares of Strides Shashun dropped over 2 per cent in Tuesday's trade after the drugmaker said it had acquired controlling stakes in Kenya's...

Drug firm Strides Shasun has acquired controlling stakes in Kenya's Universal Corporation and Australia-based Generic Partners Holdings.

Natco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.

“The Meiji Group wants to enter the global generics field, particularly in Asia and emerging countries,” said the company press release.

Emcure Pharmaceuticals has a pan India marketing and distribution presence with a field force of more than 4,800 personnel, as of March 31,...

Dr. Reddy's Laboratories and Japan's Fujifilm Corp have decided to terminate joint venture partnership they entered into in July 2011.

Pfizer Inc has terminated a deal to sell Biocon's insulin products globally, dealing the Indian company a blow and calling into question si...

Experts feel that after allowing 90% price erosion once generic drug versions appear in the market, and due to intense competition, the act...

UK-based GSK on Thursday entered into an alliance with South African generic firm Aspen Pharma to sell the latter’s generic drugs in severa...

With anti-cancer blockbuster drugs set to go off-patent in the US in the next three to four years, generic players are gearing up to tap th...